Clinical value of soluble CD40 ligand in coronary heart disease patients
Inflammation and thrombosis play an important role in pathogenesis of various cardiovascular diseases (CVD). The studies on atherosclerosis and acute coronary syndrome (ACS) pathogenesis have demonstrated the interaction of these two systems. One of the mechanisms linking inflammation and thrombosis...
| المؤلفون الرئيسيون: | , , |
|---|---|
| التنسيق: | مقال |
| اللغة: | Russian |
| منشور في: |
«SILICEA-POLIGRAF» LLC
1970-01-01
|
| سلاسل: | Кардиоваскулярная терапия и профилактика |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://cardiovascular.elpub.ru/jour/article/view/1673 |
| _version_ | 1827064181997699072 |
|---|---|
| author | O. P. Shevchenko O. F. Prirodova A. O. Shevchenko |
| author_facet | O. P. Shevchenko O. F. Prirodova A. O. Shevchenko |
| author_sort | O. P. Shevchenko |
| collection | DOAJ |
| description | Inflammation and thrombosis play an important role in pathogenesis of various cardiovascular diseases (CVD). The studies on atherosclerosis and acute coronary syndrome (ACS) pathogenesis have demonstrated the interaction of these two systems. One of the mechanisms linking inflammation and thrombosis is activation of signal system CD40/CD40L. CD40 and CD40 ligand (CD40L) are transmembrane glycoproteins, related to tumor necrosis factor (TNF) receptor family and TNF family, respectively. CD40 and CD40F are expressed by various cells, including atherosclerotic plaque cells: В-lymphocytes, macrophages/monocytes, endotheliocytes and smooth myocytes. Recently, it has been discovered that platelets can be a source of soluble CD40L form (sCD40FL. In recent clinical trials, diagnostic and prognostic role of sCD40L had been studied in patients with coronary heart disease (CHD). In individuals with myocardial infarction and unstable angina, sCD40L levels are significantly higher than in healthy persons or patients with stable angina. Prognostic sCD40L value was investigated in healthy women and ACS patients; high sCD40L levels independently predicted increased CVD risk. Raised plasma levels of sCD40L are associated with restenosis after balloon coronary angioplasty. Moreover, sCD40L concentrations are increased in Type 1 and 2 diabetes mellitus, hypercholesterolemia, acute cerebral ischemia, smoking, primary and secondary pulmonary hypertension. Therefore, sCD40L could be regarded as inflammation and thrombosis marker. Its increase is a CVD risk factor, associated with poor prognosis in CHD patients. |
| first_indexed | 2024-04-10T03:41:55Z |
| format | Article |
| id | doaj.art-a3a9e438a3764d688ed81f1c25589b4b |
| institution | Directory Open Access Journal |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| last_indexed | 2025-03-19T22:43:04Z |
| publishDate | 1970-01-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj.art-a3a9e438a3764d688ed81f1c25589b4b2024-10-17T12:21:20Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01251970-01-01571011111391Clinical value of soluble CD40 ligand in coronary heart disease patientsO. P. Shevchenko0O. F. Prirodova1A. O. Shevchenko2Russian State Medical University, Clinical Hospital of the Russian Federation President Administration. MoscowRussian State Medical University, Clinical Hospital of the Russian Federation President Administration. MoscowRussian State Medical University, Clinical Hospital of the Russian Federation President Administration. MoscowInflammation and thrombosis play an important role in pathogenesis of various cardiovascular diseases (CVD). The studies on atherosclerosis and acute coronary syndrome (ACS) pathogenesis have demonstrated the interaction of these two systems. One of the mechanisms linking inflammation and thrombosis is activation of signal system CD40/CD40L. CD40 and CD40 ligand (CD40L) are transmembrane glycoproteins, related to tumor necrosis factor (TNF) receptor family and TNF family, respectively. CD40 and CD40F are expressed by various cells, including atherosclerotic plaque cells: В-lymphocytes, macrophages/monocytes, endotheliocytes and smooth myocytes. Recently, it has been discovered that platelets can be a source of soluble CD40L form (sCD40FL. In recent clinical trials, diagnostic and prognostic role of sCD40L had been studied in patients with coronary heart disease (CHD). In individuals with myocardial infarction and unstable angina, sCD40L levels are significantly higher than in healthy persons or patients with stable angina. Prognostic sCD40L value was investigated in healthy women and ACS patients; high sCD40L levels independently predicted increased CVD risk. Raised plasma levels of sCD40L are associated with restenosis after balloon coronary angioplasty. Moreover, sCD40L concentrations are increased in Type 1 and 2 diabetes mellitus, hypercholesterolemia, acute cerebral ischemia, smoking, primary and secondary pulmonary hypertension. Therefore, sCD40L could be regarded as inflammation and thrombosis marker. Its increase is a CVD risk factor, associated with poor prognosis in CHD patients.https://cardiovascular.elpub.ru/jour/article/view/1673soluble сd40 ligandcoronary heart diseaserisk factors |
| spellingShingle | O. P. Shevchenko O. F. Prirodova A. O. Shevchenko Clinical value of soluble CD40 ligand in coronary heart disease patients Кардиоваскулярная терапия и профилактика soluble сd40 ligand coronary heart disease risk factors |
| title | Clinical value of soluble CD40 ligand in coronary heart disease patients |
| title_full | Clinical value of soluble CD40 ligand in coronary heart disease patients |
| title_fullStr | Clinical value of soluble CD40 ligand in coronary heart disease patients |
| title_full_unstemmed | Clinical value of soluble CD40 ligand in coronary heart disease patients |
| title_short | Clinical value of soluble CD40 ligand in coronary heart disease patients |
| title_sort | clinical value of soluble cd40 ligand in coronary heart disease patients |
| topic | soluble сd40 ligand coronary heart disease risk factors |
| url | https://cardiovascular.elpub.ru/jour/article/view/1673 |
| work_keys_str_mv | AT opshevchenko clinicalvalueofsolublecd40ligandincoronaryheartdiseasepatients AT ofprirodova clinicalvalueofsolublecd40ligandincoronaryheartdiseasepatients AT aoshevchenko clinicalvalueofsolublecd40ligandincoronaryheartdiseasepatients |